article thumbnail

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development. Learn more at koneksahealth.com.

article thumbnail

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

Digital Health Global

About Koneksa Koneksa is a healthcare technology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. These adverse events often lead to hospitalizations and treatment interruptions that can reduce treatment efficacy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Lloyd Price

Exec Summary: Generative AI is a powerful new tool with the potential to revolutionize healthcare. It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. But how can healthcare organisations best leverage this technology? Visit www.nelsonadvisors.co.uk

article thumbnail

Nvidia spends $1 Billion acquiring Two Israeli AI startups with massive HealthTech and Healthcare AI potential

Lloyd Price

Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. To support their strategy, Nvidia recently acquired both Deci and Run AI, making a significant move in the AI landscape.

article thumbnail

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

Exec Summary: To win the hearts and minds of the public in England and successfully deliver the NHS Federated Data Platform (FDP), Palantir should focus on the following strategies: Address Privacy Concerns: Public trust is paramount, particularly when dealing with sensitive patient data. Email lloyd@nelsonadvisors.co.uk Subscribe Today!

article thumbnail

What can Healthcare AI learn from Weather AI?

Lloyd Price

Healthcare AI can adopt similar strategies to integrate and analyse diverse patient data, including medical records, environmental factors, genetic data, and sensor data from wearables. Healthcare AI can learn several valuable things from weather AI: 1. Visit www.nelsonadvisors.co.uk Visit www.nelsonadvisors.co.uk

article thumbnail

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

Digital Health Global

“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.